Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 91,936 shares at $1.53 ($142K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.53 | 33,450 | $51K | 35.9% |
| 2 | $1.53 | 33,450 | $51K | 35.9% |
| 3 | $1.57 | 5,036 | $8K | 5.5% |
| 4 | $1.61 | 20,000 | $32K | 22.6% |
| Total | $1.55 avg | 91,936 | $142K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |